Skip to main content
Premium Trial:

Request an Annual Quote

SciGene to Manufacture BlueGnome Systems

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BlueGnome announced yesterday that SciGene will manufacture its new range of ClearHyb hybridization and wash systems.

The manufacturing and supply deal marks BlueGnome's entry into the microarray hardware market. The Cambridge, UK-based firm offers microarray consumables and solutions for screening chromosomal abnormalities in cytogenetics and in vitro fertilization.

According to GenomeWeb Daily News sister publication BioArray News, BlueGnome's increased sales to customers in different geographies prompted the firm's decision to directly offer all laboratory equipment associated with microarray processing.

Sunnyvale, Calif.-based SciGene develops instruments that automate workflows used with microarray-based procedures in research and clinical diagnostic laboratories.

The firms expect to begin shipping the new ClearHyb instruments in August.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.